OrbiMed — 2016 Investments
8 investments dated 2016 · listed companies and verified rows first · show all
Prelude Therapeutics is a precision oncology company developing cancer treatments for areas of high unmet need, with a pipeline including selective KAT6A degraders and mutant-selective JAK2V617F JH2 inhibitors.
BiotechHealthtechNewark, US
Krishna Vaddi(Executive Officer, Director)
BoardPaul Friedman(Director of Issuer)
Board seatDavid Bonita· per SEC Form D
Co-investorsThe Innovation Space
San Jose, US
Mark Reiley(Director)Jeffrey W. Dunn(Executive Officer, Director)Laura Francis(Executive Officer)Robert E. Johnson(Executive Officer)Jeffrey Dunn(Executive Officer, Director)Greg Hinckley(Director)
Board seatDavid Bonita· per SEC Form D · $21M raise · filed Jun 2016
Co-investorsArboretum Ventures
BiotechCincinnati, US
Joseph H. Gardner(Executive Officer)Joseph Gardner(Founder)inDuane Nash(Director)Kevin Peters(Executive Officer)Steve Pakola(Executive Officer)Robert Shalwitz(Executive Officer)
Board seatChau Khuong· per SEC Form D · $9.2M raise · filed Apr 2016
Co-investorsCincyTechSofinnova Ventures
BiotechCambridge, US
James McLaughlin(Executive Officer, Director)
BoardJean George(Director)Jason Rhodes(Director)
Board seatCarl Gordon· per SEC Form D
Co-investorsLightstone VenturesAtlas Venture
Inspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective.
Digital HealthHealthtechMedical DevicesGolden Valley, US
Timothy Herbert(Executive Officer, Director)Tim Herbert(Founder)inJerry Griffin(Director)Gary Brothers(Director)Mudit Jain(Director)Marilyn Nelson(Director)
Board seatChau Khuong· per SEC Form D · $37.5M raise · filed Nov 2016
Co-investorsAmzak HealthAPERTURE Venture PartnersUS Venture Partners
BiotechBoston, US
Darlene Deptula-Hicks(Executive Officer)Stephen S. Yoder(Executive Officer, Director)Darlene M. Deptula-Hicks(Acting Chief Financial Officer)Christina Takke(Director)
BoardSteven Prelack(Director)
Board seatChau Khuong· per SEC Form D · $16.5M raise · filed Jun 2016
BiotechNewark, US
Robert Jacks(Executive Officer)Joseph Amprey(Executive Officer)
BoardThomas Beck(Director)Ben Auspitz(Director)
Board seatRishi GuptaKlaus Veitinger· per SEC Form D · $6M raise · filed May 2016
BiotechSouth San Francisco, US
Gerrit Klaerner(Executive Officer, Director)Melissa Miksch(Executive Officer)
BoardSandra Coufal(Director)Robert Alpern(Director)
Board seatKlaus VeitingerDavid Bonita· per SEC Form D · $55.5M raise · filed Jul 2016
Co-investorsAvoro Capital AdvisorsLongitude Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.